#1323006: Cardiometabolic Risk Factors and Insulin Therapy Requirement in Youth with New Onset Type 2 Diabetes during the COVID-19 Pandemic

Abstract

The incidence of type 2 diabetes (T2D) in youth increased remarkably during the COVID-19 pandemic. We hypothesized that most youth diagnosed with T2D during the COVID-19 pandemic already had abnormal cardiometabolic risk factors before the pandemic. Thus, we aim to determine what specific cardiometabolic risk factors were associated with the requirement of insulin therapy (HbA1C >=8.5%) in youth with a new diagnosis of T2D.